APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Biotechnology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal Biotechnology Market Outlook and Growth Opportunities 2026

20 December 2025196 pages

Choose your research edition.

Industry ResearchAnimal Biotechnology Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Biotechnology Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Animal Biotechnology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Biotechnology Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Biotechnology Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Animal Biotechnology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal Biotechnology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal Biotechnology market include Biogenesis Bago, Boehringer Inghlem, Santa Cruz Biotechnology, Inc., Virbac Inc., Bayer AG, Pfizer, Inc., Merck &, Inc., Sanofi and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Animal Biotechnology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Biotechnology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Biotechnology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Animal Biotechnology market.

Animal Biotechnology Segment by Company

Biogenesis Bago

Boehringer Inghlem

Santa Cruz Biotechnology, Inc.

Virbac Inc.

Bayer AG

Pfizer, Inc.

Merck &, Inc.

Sanofi

Zoetis

Animal Biotechnology Segment by Type

Diagnostic Tests

Vaccines

Drugs

Reporductive & Genetic Produtcs

Animal Biotechnology Segment by Application

Food Safety and Drug Development

Preventive Care for Animals

Development of Animal Pharmaceuticals

Others

Animal Biotechnology Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Animal Biotechnology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Animal Biotechnology key companies, revenue, market share, and recent developments.

3. To split the Animal Biotechnology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Animal Biotechnology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal Biotechnology significant trends, drivers, influence factors in global and regions.

6. To analyze Animal Biotechnology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Biotechnology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Biotechnology industry.

Chapter 3: Detailed analysis of Animal Biotechnology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Animal Biotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Animal Biotechnology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal Biotechnology Industry Trends Table 2. Animal Biotechnology Industry Drivers Table 3. Animal Biotechnology Industry Opportunities and Challenges Table 4. Animal Biotechnology Industry Restraints Table 5. Global Animal Biotechnology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal Biotechnology Revenue Share by Company (2021-2026) Table 7. Global Animal Biotechnology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Animal Biotechnology Key Company Manufacturing Base & Headquarters Table 9. Global Animal Biotechnology Company, Product Type & Application Table 10. Global Animal Biotechnology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Animal Biotechnology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Diagnostic Tests Table 15. Significant Companies of Vaccines Table 16. Significant Companies of Drugs Table 17. Significant Companies of Reporductive & Genetic Produtcs Table 18. Global Animal Biotechnology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Animal Biotechnology Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Animal Biotechnology Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Animal Biotechnology Sales Value Share by Type (2021-2026) Table 22. Global Animal Biotechnology Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Food Safety and Drug Development Table 24. Significant Companies of Preventive Care for Animals Table 25. Significant Companies of Development of Animal Pharmaceuticals Table 26. Significant Companies of Others Table 27. Global Animal Biotechnology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Animal Biotechnology Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Animal Biotechnology Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Animal Biotechnology Sales Value Share by Application (2021-2026) Table 31. Global Animal Biotechnology Sales Value Share by Application (2027-2032) Table 32. Global Animal Biotechnology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Animal Biotechnology Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Animal Biotechnology Sales Value Share by Region (2021-2026) Table 35. Global Animal Biotechnology Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Animal Biotechnology Sales Value Share by Region (2027-2032) Table 37. Global Animal Biotechnology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Animal Biotechnology Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Animal Biotechnology Sales Value Market Share by Country (2021-2026) Table 40. Global Animal Biotechnology Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Animal Biotechnology Sales Value Market Share by Country (2027-2032) Table 42. Biogenesis Bago Company Information Table 43. Biogenesis Bago Business Overview Table 44. Biogenesis Bago Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Biogenesis Bago Animal Biotechnology Product Portfolio Table 46. Biogenesis Bago Recent Development Table 47. Boehringer Inghlem Company Information Table 48. Boehringer Inghlem Business Overview Table 49. Boehringer Inghlem Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Boehringer Inghlem Animal Biotechnology Product Portfolio Table 51. Boehringer Inghlem Recent Development Table 52. Santa Cruz Biotechnology, Inc. Company Information Table 53. Santa Cruz Biotechnology, Inc. Business Overview Table 54. Santa Cruz Biotechnology, Inc. Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Santa Cruz Biotechnology, Inc. Animal Biotechnology Product Portfolio Table 56. Santa Cruz Biotechnology, Inc. Recent Development Table 57. Virbac Inc. Company Information Table 58. Virbac Inc. Business Overview Table 59. Virbac Inc. Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Virbac Inc. Animal Biotechnology Product Portfolio Table 61. Virbac Inc. Recent Development Table 62. Bayer AG Company Information Table 63. Bayer AG Business Overview Table 64. Bayer AG Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Bayer AG Animal Biotechnology Product Portfolio Table 66. Bayer AG Recent Development Table 67. Pfizer, Inc. Company Information Table 68. Pfizer, Inc. Business Overview Table 69. Pfizer, Inc. Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Pfizer, Inc. Animal Biotechnology Product Portfolio Table 71. Pfizer, Inc. Recent Development Table 72. Merck &, Inc. Company Information Table 73. Merck &, Inc. Business Overview Table 74. Merck &, Inc. Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck &, Inc. Animal Biotechnology Product Portfolio Table 76. Merck &, Inc. Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sanofi Animal Biotechnology Product Portfolio Table 81. Sanofi Recent Development Table 82. Zoetis Company Information Table 83. Zoetis Business Overview Table 84. Zoetis Animal Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Zoetis Animal Biotechnology Product Portfolio Table 86. Zoetis Recent Development Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Animal Biotechnology Product Image Figure 2. Global Animal Biotechnology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Biotechnology Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal Biotechnology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Diagnostic Tests Image Figure 8. Vaccines Image Figure 9. Drugs Image Figure 10. Reporductive & Genetic Produtcs Image Figure 11. Global Animal Biotechnology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Animal Biotechnology Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Animal Biotechnology Sales Value Share by Type (2021-2032) Figure 14. Food Safety and Drug Development Image Figure 15. Preventive Care for Animals Image Figure 16. Development of Animal Pharmaceuticals Image Figure 17. Others Image Figure 18. Global Animal Biotechnology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Animal Biotechnology Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Animal Biotechnology Sales Value Share by Application (2021-2032) Figure 21. Global Animal Biotechnology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Animal Biotechnology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Animal Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 24. North America Animal Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Animal Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Animal Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Animal Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Animal Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Animal Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 30. South America Animal Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Animal Biotechnology Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Animal Biotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Animal Biotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Animal Biotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Animal Biotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Tests
  • Vaccines
  • Drugs
  • Reporductive & Genetic Produtcs
Applications
  • Food Safety and Drug Development
  • Preventive Care for Animals
  • Development of Animal Pharmaceuticals
  • Others
Companies covered
  • Biogenesis Bago
  • Boehringer Inghlem
  • Santa Cruz Biotechnology, Inc.
  • Virbac Inc.
  • Bayer AG
  • Pfizer, Inc.
  • Merck &, Inc.
  • Sanofi
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Animal Biotechnology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Animal Biotechnology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Animal Biotechnology Market Dynamics
  1. 2.1 Animal Biotechnology Industry Trends
  2. 2.2 Animal Biotechnology Industry Drivers
  3. 2.3 Animal Biotechnology Industry Opportunities and Challenges
  4. 2.4 Animal Biotechnology Industry Restraints
3 Animal Biotechnology Market by Company
  1. 3.1 Global Animal Biotechnology Company Revenue Ranking in 2025
  2. 3.2 Global Animal Biotechnology Revenue by Company (2021-2026)
  3. 3.3 Global Animal Biotechnology Company Ranking (2024-2026)
  4. 3.4 Global Animal Biotechnology Company Manufacturing Base and Headquarters
  5. 3.5 Global Animal Biotechnology Company Product Type and Application
  6. 3.6 Global Animal Biotechnology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Animal Biotechnology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Animal Biotechnology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Animal Biotechnology Market by Type
  1. 4.1 Animal Biotechnology Type Introduction
  2. 4.1.1 Diagnostic Tests
  3. 4.1.2 Vaccines
  4. 4.1.3 Drugs
  5. 4.1.4 Reporductive & Genetic Produtcs
  6. 4.2 Global Animal Biotechnology Sales Value by Type
  7. 4.2.1 Global Animal Biotechnology Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Animal Biotechnology Sales Value by Type (2021-2032)
  9. 4.2.3 Global Animal Biotechnology Sales Value Share by Type (2021-2032)
5 Animal Biotechnology Market by Application
  1. 5.1 Animal Biotechnology Application Introduction
  2. 5.1.1 Food Safety and Drug Development
  3. 5.1.2 Preventive Care for Animals
  4. 5.1.3 Development of Animal Pharmaceuticals
  5. 5.1.4 Others
  6. 5.2 Global Animal Biotechnology Sales Value by Application
  7. 5.2.1 Global Animal Biotechnology Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Animal Biotechnology Sales Value by Application (2021-2032)
  9. 5.2.3 Global Animal Biotechnology Sales Value Share by Application (2021-2032)
6 Animal Biotechnology Regional Value Analysis
  1. 6.1 Global Animal Biotechnology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Biotechnology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Animal Biotechnology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Animal Biotechnology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Animal Biotechnology Sales Value (2021-2032)
  7. 6.3.2 North America Animal Biotechnology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Animal Biotechnology Sales Value (2021-2032)
  10. 6.4.2 Europe Animal Biotechnology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Animal Biotechnology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Animal Biotechnology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Animal Biotechnology Sales Value (2021-2032)
  16. 6.6.2 South America Animal Biotechnology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Animal Biotechnology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Animal Biotechnology Sales Value Share by Country, 2025 VS 2032
7 Animal Biotechnology Country-level Value Analysis
  1. 7.1 Global Animal Biotechnology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal Biotechnology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Animal Biotechnology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Animal Biotechnology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Animal Biotechnology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Animal Biotechnology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Animal Biotechnology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Animal Biotechnology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Animal Biotechnology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Animal Biotechnology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Animal Biotechnology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Animal Biotechnology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Animal Biotechnology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Animal Biotechnology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Animal Biotechnology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Animal Biotechnology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Animal Biotechnology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Animal Biotechnology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Animal Biotechnology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Animal Biotechnology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Animal Biotechnology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Animal Biotechnology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Animal Biotechnology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Animal Biotechnology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Animal Biotechnology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Animal Biotechnology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Animal Biotechnology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Animal Biotechnology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Animal Biotechnology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Animal Biotechnology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Animal Biotechnology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Animal Biotechnology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Animal Biotechnology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Animal Biotechnology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogenesis Bago
  2. 8.1.1 Biogenesis Bago Company Information
  3. 8.1.2 Biogenesis Bago Business Overview
  4. 8.1.3 Biogenesis Bago Animal Biotechnology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biogenesis Bago Animal Biotechnology Product Portfolio
  6. 8.1.5 Biogenesis Bago Recent Developments
  7. 8.2 Boehringer Inghlem
  8. 8.2.1 Boehringer Inghlem Company Information
  9. 8.2.2 Boehringer Inghlem Business Overview
  10. 8.2.3 Boehringer Inghlem Animal Biotechnology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Inghlem Animal Biotechnology Product Portfolio
  12. 8.2.5 Boehringer Inghlem Recent Developments
  13. 8.3 Santa Cruz Biotechnology, Inc.
  14. 8.3.1 Santa Cruz Biotechnology, Inc. Company Information
  15. 8.3.2 Santa Cruz Biotechnology, Inc. Business Overview
  16. 8.3.3 Santa Cruz Biotechnology, Inc. Animal Biotechnology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Santa Cruz Biotechnology, Inc. Animal Biotechnology Product Portfolio
  18. 8.3.5 Santa Cruz Biotechnology, Inc. Recent Developments
  19. 8.4 Virbac Inc.
  20. 8.4.1 Virbac Inc. Company Information
  21. 8.4.2 Virbac Inc. Business Overview
  22. 8.4.3 Virbac Inc. Animal Biotechnology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Inc. Animal Biotechnology Product Portfolio
  24. 8.4.5 Virbac Inc. Recent Developments
  25. 8.5 Bayer AG
  26. 8.5.1 Bayer AG Company Information
  27. 8.5.2 Bayer AG Business Overview
  28. 8.5.3 Bayer AG Animal Biotechnology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer AG Animal Biotechnology Product Portfolio
  30. 8.5.5 Bayer AG Recent Developments
  31. 8.6 Pfizer, Inc.
  32. 8.6.1 Pfizer, Inc. Company Information
  33. 8.6.2 Pfizer, Inc. Business Overview
  34. 8.6.3 Pfizer, Inc. Animal Biotechnology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer, Inc. Animal Biotechnology Product Portfolio
  36. 8.6.5 Pfizer, Inc. Recent Developments
  37. 8.7 Merck &, Inc.
  38. 8.7.1 Merck &, Inc. Company Information
  39. 8.7.2 Merck &, Inc. Business Overview
  40. 8.7.3 Merck &, Inc. Animal Biotechnology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck &, Inc. Animal Biotechnology Product Portfolio
  42. 8.7.5 Merck &, Inc. Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Animal Biotechnology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Animal Biotechnology Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Animal Biotechnology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Animal Biotechnology Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst